Metallothioneins (MTs) are a family of small, cysteine-rich that play crucial roles in metal homeostasis, antioxidant defense, and neuroprotection in the central nervous system. These versatile are expressed throughout the brain in [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), and [microglia](/cell-types/microglia-neuroinflammation), where they buffer metal ions, scavenge [reactive oxygen species](/entities/reactive-oxygen-species), and modulate neuroinflammatory responses. MT-3 (metallothionein-3), also known as growth inhibitory factor (GIF), is particularly abundant in the brain and has been implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. This page explores the structure, isoforms, neuroprotective , and therapeutic potential of metallothioneins in neurodegeneration.
Metallothioneins (MTs) are a family of small, cysteine-rich that play crucial roles in metal homeostasis, antioxidant defense, and neuroprotection in the central nervous system. These versatile are expressed throughout the brain in [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), and [microglia](/cell-types/microglia-neuroinflammation), where they buffer metal ions, scavenge [reactive oxygen species](/entities/reactive-oxygen-species), and modulate neuroinflammatory responses. MT-3 (metallothionein-3), also known as growth inhibitory factor (GIF), is particularly abundant in the brain and has been implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. This page explores the structure, isoforms, neuroprotective , and therapeutic potential of metallothioneins in neurodegeneration.
Metallothioneins (MTs)
Metallothioneins (MTs) are a family of small, cysteine-rich (typically 60-68 amino acids) characterized by their high affinity for divalent metal ions and potent antioxidant properties[@metallothionein2021]. In the brain, metallothioneins play essential roles in metal homeostasis, oxidative stress protection, neuroinflammation modulation, and neuronal survival[@metallothionein2022]. These are increasingly recognized for their involvement in neurodegenerative including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
Cysteine-rich composition: 20 conserved cysteine residues (30% of total amino acids)
Metal-thiolate clusters: Zn(II)-thiolate clusters (Zn₇MT) that serve as zinc buffers
Metal-binding versatility: Can bind Zn²⁺, Cu⁺, Cd²⁺, Hg²⁺, and Fe²⁺
Reduced domain organization: Two domains (β and α) with distinct metal-binding properties
The cysteine sulfhydryl groups (-SH) confer exceptional redox activity, allowing MTs to neutralize reactive oxygen species (ROS) and maintain cellular redox balance[@metallothionein2021].
Types in the Brain
MT-1 (Metallothionein-1)
Primarily expressed in astrocytes
Highly inducible by cytokines, metals, and oxidative stress
Critical for metal detoxification and astrocyte-neuron communication
Upregulated in response to brain injury
MT-2 (Metallothionein-2)
Ubiquitous expression throughout the brain
Constitutively expressed at higher levels than MT-1
Protective role in various neurodegenerative conditions
Important for synaptic function and plasticity
MT-3 (Metallothionein-3)
Neuron-specific isoform, also called growth inhibitory factor (GIF)
Highly expressed in cortical neurons, hippocampal pyramidal cells, and Purkinje cells
Distinct metal-binding properties compared to MT-1/MT-2
Critical for zinc and copper homeostasis in neurons
MT-4 (Metallothionein-4)
Primarily expressed in squamous epithelial cells
Limited expression in brain
Less characterized in neurodegeneration
Neuroprotective Mechanisms
Antioxidant Defense
Metallothioneins protect neurons through multiple antioxidant :
Direct free radical scavenging: Cysteine residues neutralize superoxide (O₂⁻), hydroxyl radical (OH•), and peroxynitrite (ONOO⁻)
Redox cycling: MTs can regenerate oxidized biomolecules
Metal homeostasis: Buffering of redox-active metals (Fe, Cu) prevents Fenton chemistry
Enzyme cofactor: MTs serve as zinc donors for antioxidant enzymes (Cu/Zn-SOD)
Anti-apoptotic Signaling
Inhibition of caspase activation
Preservation of mitochondrial integrity
Modulation of Bcl-2 family
Activation of neuroprotective signaling pathways (PI3K/Akt, MAPK/ERK)
Anti-inflammatory Effects
Suppression of microglial activation
Reduction in pro-inflammatory cytokine production (IL-1β, TNF-α, IL-6)
Modulation of [NF-κB](/entities/nf-kb) signaling
Promotion of anti-inflammatory phenotype in astrocytes
Neurotransmission Modulation
Zinc and copper homeostasis at synapses
Modulation of [NMDA receptor](/entities/nmda-receptor) activity
Regulation of GABAergic and glutamatergic signaling
Involvement in [long-term potentiation](/mechanisms/long-term-potentiation) (LTP) and memory
Role in Neurodegenerative Diseases
Alzheimer's Disease
MT-3 was originally identified as a growth inhibitory factor that is deficient in AD brain[@metallothionein2020]:
Reduced expression: MT-3 levels are significantly decreased in AD [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex)
Zinc dysregulation: Loss of MT-3 contributes to extracellular zinc accumulation near amyloid plaques